Company intelligence / Profile preview

Neosensory

Palo Alto, California, United Statesneosensory.com ↗

Ownership: Private
Development stage: Commercial

Overview

Neosensory has developed and commercialized non-invasive wearable devices that translate sound into vibrational patterns on the skin, enabling users—including those with hearing loss or tinnitus—to perceive auditory information through touch. Their flagship product, Buzz, is used by both consumers and people with hearing impairments. The company also launched a science-backed bimodal stimulation program for tinnitus management in 2021[5][6].

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapyWearable technology
Industry: Assistive Medical Devices

Drug pipeline

2 assets

Clarify

Commercial

Indications: Hearing loss

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Neosensory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neosensory.

Explore the full profile